Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    IFCAH-ESPE Grant

    IFCAH-ESPE Grant supports academic researchers studying congenital adrenal hyperplasia mechanisms, complications, and new therapies to improve treatment and patients’ health and quality of life.

    OverviewSimilar Grants
    OverviewSimilar Grants

    This grant was recently updated

    The letter-of-intent deadline moved from 15 January 2026 to 15 January 2027, and full applications for accepted LOIs moved from April 2026 to April 2027. The remaining selection schedule also shifted to 2027, and updated call guidelines and a 2027 LOI form are available.

    Funder: European Society for Paediatric Endocrinology

    Due Dates: January 15, 2027 (LOI) | April 30, 2027 (Invited full application; exact day not specified)

    Funding Amounts: Up to €150,000 per project for up to three years; €350,000 total available

    Summary: Supports academic research on congenital adrenal hyperplasia mechanisms, complications, and new therapies to improve patients’ health and quality of life.

    Key Information: Applicants must hold an M.D., Ph.D., or equivalent degree and a faculty position or equivalent.


    Description

    The IFCAH-ESPE Grant supports academic research to improve treatment and quality of life for people with congenital adrenal hyperplasia (CAH). IFCAH, founded in 2010 by parents of children affected by CAH, runs an annual call with the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). The program encourages original research that advances understanding of the disease and develops new therapeutic approaches.

    Priorities include CAH pathophysiology; adrenal development, differentiation, and homeostasis with clear relevance to CAH; and prevention, diagnosis, and treatment of natural or treatment-related complications. Relevant complications include effects on foetal development, growth, puberty, metabolism, cardiovascular health, fertility, bone density, immunity, infection, and neurocognition. Research may also address new therapeutic targets and protocols, pharmacotherapy, and gene or cellular therapy models.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.